Association between Chronic Obstructive Pulmonary Disease and Lung Cancer: A Case-Control Study in Southern Chinese and a Meta-Analysis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wang, Hui ^a   Yang, Lei ^a   Zou, Linnan ^a   Huang, Dongsheng ^a,c   Guo, Yuan ^a   Pan, Mingan ^d   Tan, Yigang ^c   Zhong, Haibo ^e   Ji, Weidong ^a   Ran, Pixin ^b   Zhong, Nanshan ^b   Lu, Jiachun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c GUANGZHOU CHEST HOSPITAL   (China)

^d THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e GUANGZHOU RED CROSS HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; BODY MASS; CANCER RISK; CHINESE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LUNG CANCER; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW;

AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 84867007012     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046144     Document Type: Article

References (71)

1. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM, (2009) Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst 101: 554-559.
2. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
3. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
4. Zhong N, Wang C, Yao W, Chen P, Kang J, et al. (2007) Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 176: 753-760.
5. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
6. Caramori G, Casolari P, Cavallesco GN, Giuffre S, Adcock I, et al. (2011) Mechanisms involved in lung cancer development in COPD. Int J Biochem Cell Biol 43: 1030-1044.
7. Adcock IM, Caramori G, Barnes PJ, (2011) Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 81: 265-284.
8. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, et al. (2009) COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 34: 380-386.
9. Young RP, Hopkins R, Eaton TE, (2007) Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 30: 616-622.
10. Petty TL, (2005) Are COPD and lung cancer two manifestations of the same disease? Chest 128: 1895-1897.
11. Rutgers SR, Postma DS, Ten HN, Kauffman HF, van Der Mark TW, et al. (2000) Ongoing airway inflammation in patients with COPD who Do not currently smoke. Chest 117: 262S.
12. Yao H, Rahman I, (2009) Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol 9: 375-383.
13. Liu B, Chen D, Yang L, Li Y, Ling X, et al. (2010) A functional variant (-1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity. Carcinogenesis 31: 1405-1411.
14. Lu J, Yang L, Zhao H, Liu B, Li Y, et al. (2011) The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations. Hum Mutat 32: 1299-1308.
15. Yang L, Li Y, Cheng M, Huang D, Zheng J, et al. (2011) A functional polymorphism at microRNA-629 binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis 33: 338-347.
16. Liu Bin, Yang Lei, Huang Binfang, Cheng Mei, Wang Hui, et al. (2012) A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Prognosis of Lung Cancer. Am J Hum Genet 91: 384-390.
17. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
19. Altman DG, Bland JM, (2003) Interaction revisited: the difference between two estimates. BMJ 326: 219.
20. Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, et al. (2010) Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 138: 1295-1302.
21. Skillrud DM, Offord KP, Miller RD, (1986) high risk of lung cancer in chronic obstructive pulmonary disease. Annals of internal Medicine 105: 503-507.
22. Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, et al. (2009) A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J 85: 515-524.
23. Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, et al. (2008) Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 168: 1097-1103.
24. Kishi K, Gurney JW, Schroeder DR, Scanlon PD, Swensen SJ, et al. (2002) The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study. Eur Respir J 19: 1093-1098.
25. Galeone C, Pelucchi C, La Vecchia C, Negri E, Bosetti C, et al. (2008) Indoor air pollution from solid fuel use, chronic lung diseases and lung cancer in Harbin, Northeast China. Eur J Cancer Prev 17: 473-478.
26. Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia RL, (2006) Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf 15: 131-138.
27. Mannino DM, Aguayo SM, Petty TL, Redd SC, (2003) Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 163: 1475-1480.
28. Mizuno S, Takiguchi Y, Fujikawa A, Motoori K, Tada Y, et al. (2009) Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology 14: 377-383.
29. Van Dyke AL, Cote ML, Wenzlaff AS, Chen W, Abrams J, et al. (2009) Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 18: 1829-1840.
30. Etzel CJ, Kachroo S, Liu M, D'Amelio A, Dong Q, et al. (2008) Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila) 1: 255-265.
31. Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, et al. (2009) Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 4: 291-299.
32. de Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, et al. (2007) Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 132: 1932-1938.
33. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, et al. (2008) Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 178: 738-744.
34. Alavanja MC, Brownson RC, Boice JJ, Hock E, (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 136: 623-632.
35. Rong GX, Xiao-ou S, Tang GY, (2010) The history of chronic pulmonray diseases and male lung cancer risk: a prospective cohort study in urban Shanghai. Tumor 30: 502-504.
36. Kreuzer M, Heinrich J, Kreienbrock L, Rosario AS, Gerken M, et al. (2002) Risk factors for lung cancer among nonsmoking women. Int J Cancer 100: 706-713.
37. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ, (2007) Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176: 285-290.
38. Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, et al. (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141: 1023-1032.
39. Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE, (1988) Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 48: 7279-7284.
40. Schabath MB, Delclos GL, Martynowicz MM, Greisinger AJ, Lu C, et al. (2005) Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol 161: 412-422.
41. Brownson RC, Alavanja MC, (2000) Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control 11: 853-858.
42. Liang H, Guan P, Yin Z, Li X, He Q, et al. (2009) Risk of lung cancer following nonmalignant respiratory conditions among nonsmoking women living in Shenyang, Northeast China. J Womens Health (Larchmt) 18: 1989-1995.
43. Mayne ST, Buenconsejo J, Janerich DT, (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 149: 13-20.
44. Osann KE, Lowery JT, Schell MJ, (2000) Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation. Lung Cancer 28: 1-10.
45. Jia-chun L, Lu-yuan S, Zhong-liang W, (2003) Case-Control Study of Human Lung Cancers in Guangzhou. CHINA J CANCER PREV TREAT 10: 673-676.
46. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, et al. (2009) Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 4: e7380.
47. Yong H, Hui X, An-Hui W, Yun-Jie W, (2005) Chronic obstructive pulmonary diseases are risk factors of lung cancer. Journal of The Fourth Military Medical University 26: 146-149.
48. Ko YC, Lee CH, Chen MJ, Huang CC, Chang WY, et al. (1997) Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol 26: 24-31.
49. Wang XR, Yu IT, Chiu YL, Qiu H, Fu Z, et al. (2009) Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control 20: 757-763.
50. Neuberger JS, Mahnken JD, Mayo MS, Field RW, (2006) Risk factors for lung cancer in Iowa women: implications for prevention. Cancer Detect Prev 30: 158-167.
51. Wu-Williams AH, Dai XD, Blot W, Xu ZY, Sun XW, et al. (1990) Lung cancer among women in north-east China. Br J Cancer 62: 982-987.
52. Brenner AV, Wang Z, Kleinerman RA, Wang L, Zhang S, et al. (2001) Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 30: 118-124.
53. Miao Z, Ya-Chen A, (2009) The risk factors of lung cancer in the rural area of Tangshan, China. Chinese Journal of Coal Industry Medicine 12: 125-127.
54. Wang SY, Hu YL, Wu YL, Li X, Chi GB, et al. (1996) A comparative study of the risk factors for lung cancer in Guangdong, China. Lung Cancer 14 (Suppl 1):: S99-S105.
55. Brenner DR, McLaughlin JR, Hung RJ, (2011) Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-Analysis. PLoS One 6: e17479.
56. Ardies CM, (2003) Inflammation as cause for scar cancers of the lung. Integr Cancer Ther 2: 238-246.
57. Brody JS, Spira A, (2006) State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc 3: 535-537.
58. Young RP, Hopkins RJ, Whittington CF, Hay BA, Epton MJ, et al. (2011) Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One 6: e16476.
59. Schwartz AG, Prysak GM, Bock CH, Cote ML, (2007) The molecular epidemiology of lung cancer. Carcinogenesis 28: 507-518.
60. Schwartz AG, Ruckdeschel JC, (2006) Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173: 16-22.
61. Engels EA, Wu X, Gu J, Dong Q, Liu J, et al. (2007) Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res 67: 6520-6527.
62. Molfino NA, (2007) Current thinking on genetics of chronic obstructive pulmonary disease. Curr Opin Pulm Med 13: 107-113.
63. Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, et al. (2004) Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 15: 819-827.
64. Purdue MP, Gold L, Jarvholm B, Alavanja MC, Ward MH, et al. (2007) Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 62: 51-56.
65. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD, (2005) Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60: 570-575.
66. Pierrou S, Broberg P, O'Donnell RA, Pawlowski K, Virtala R, et al. (2007) Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175: 577-586.
67. Borczuk AC, Powell CA, (2007) Expression profiling and lung cancer development. Proc Am Thorac Soc 4: 127-132.
68. Santillan AA, Camargo CJ, Colditz GA, (2003) A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 14: 327-334.
69. Schabath MB, Gorlova OY, Spitz MR, (2006) Re: "Cancer mortality among US men and women with asthma and hay fever". Am J Epidemiol 163: 394-395, 395-396.
70. Littman AJ, Jackson LA, Vaughan TL, (2005) Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 14: 773-778.
71. Zeki AA, Schivo M, Chan AL, Hardin KA, Kenyon NJ, et al. (2010) Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 34: J327-J338.